Trials / Unknown
UnknownNCT05278897
Hyaluronic Acid for Soft Tissue Injuries
Soft Tissue Adapted Hyaluronic Acid Functional Evaluation (SAFE): A Prospective Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Global Research Solutions · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Soft Tissue Adapted Biocompatible Hyaluronic Acid, or STABHA™, has demonstrated varying degrees efficacy in patients treated for common musculoskeletal tendinopathies and ligament injuries, such as ankle sprains, lateral elbow tendinopathy, and rotator cuff tendinopathies. Factors associated with prognosis following treatment remain largely unknown. Identifying appropriate patient populations for use of STABHA™ is a necessary first step to facilitate the design of future clinical trials in the management of acute and chronic musculoskeletal soft-tissue injuries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Soft Tissue Adapted Biocompatible Hyaluronic Acid | 1% sodium hyaluronate |
Timeline
- Start date
- 2022-03-14
- Primary completion
- 2024-05-13
- Completion
- 2024-05-13
- First posted
- 2022-03-14
- Last updated
- 2022-03-14
Source: ClinicalTrials.gov record NCT05278897. Inclusion in this directory is not an endorsement.